Cramer's lightning round: Buy Hinge Health

August 12, 2026 - 15:52

On the latest episode of "Mad Money," Jim Cramer hit the lightning round, offering his usual fast-paced verdicts on caller-submitted stocks. One name that stood out was Hinge Health, the digital musculoskeletal care company. Cramer didn't hesitate, telling the caller to buy the stock.

His reasoning wasn't complicated. Hinge Health is riding a strong wave in digital health, specifically in treating chronic back and joint pain through app-based physical therapy and coaching. Cramer pointed out that the company has a solid subscription model and is growing its client base among employers and health plans. He sees the recent pullback in the stock as a buying opportunity rather than a warning sign.

Cramer also noted that the market has been too quick to punish digital health names across the board, even when the fundamentals are improving. He argued that Hinge Health's revenue growth and path to profitability are better than many of its peers, and that the company is gaining traction in a space with huge demand.

Of course, the lightning round is not a deep dive. Cramer's advice is based on his quick read of the charts and recent news. But for the caller, the message was clear: if you're looking for exposure to digital health, Hinge Health is a name worth owning. As always, he reminded viewers to do their own research, but his tone suggested he's confident in this one.